LEVELS OF CIRCULATING COLLAGENASE, STROMELYSIN-1, AND TISSUE INHIBITOR OF MATRIX METALLOPROTEINASES-1 INPATIENTS WITH RHEUMATOID-ARTHRITIS - RELATIONSHIP TO SERUM LEVELS OF ANTIGENIC KERATAN SULFATE AND SYSTEMIC PARAMETERS OF INFLAMMATION

被引:133
作者
MANICOURT, DH
FUJIMOTO, N
OBATA, K
THONAR, EJMA
机构
[1] ST LUC UNIV HOSP,BRUSSELS,BELGIUM
[2] FUJI CHEM IND CO LTD,TOYAMA,JAPAN
[3] RUSH PRESBYTERIAN ST LUKES MED CTR,CHICAGO,IL 60612
来源
ARTHRITIS AND RHEUMATISM | 1995年 / 38卷 / 08期
关键词
D O I
10.1002/art.1780380803
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To measure serum levels of matrix metalloproteinase-1 (MMP-1), matrix metalloproteinase- 3 (MMP-3), and tissue inhibitor of MMP-1 (TIMP-1) in patients with rheumatoid arthritis (RA) and in age-matched control subjects, and to determine how these correlate with serum levels of antigenic keratan sulfate (KS) and other biochemical and clinical indicators of disease activity. Methods. Immunoassays were used to measure levels of MMP-1, MMP-3, TIMP-1, and antigenic KS, Radiologic and functional joint scores were based upon Steinbrocker's criteria, Erythrocyte sedimentation rates (ESR) and levels of C-reactive proteins (GRIP) were measured. Results. In RA patients, levels of MMP-3 and TIMP-1 were significantly increased, and strongly correlated with the ESR and CRP levels but,not with radiologic or functional joint scores. Levels of antigenic KS were significantly lower in RA patients and correlated negatively with systemic parameters of inflammation and serum levels of TIMP-1. Conclusions, The increase in serum levels of MMP-3 and TIMP-1 appears to reflect systemic inflammation in RA. The inverse correlation between serum levels of TIMP-1 and antigenic KS suggests that an upregulation of TIMP-1 synthesis might be responsible for the apparent suppression of cartilage aggrecan catabolism in patients with severe inflammatory changes.
引用
收藏
页码:1031 / 1039
页数:9
相关论文
共 56 条
[1]  
Harris ED, Evanson JM, Di Bona DR, Krane SM, Collagenase and rheumatoid arthritis, Arthritis Rheum, 13, pp. 83-94, (1970)
[2]  
Woessner JF, Howell DS, Hydrolytic enzymes in cartilage, Studies in Joint Diseases, 1, (1983)
[3]  
Mainardi CL, Biochemical mechanisms of articular destruction, Rheum Dis Clin North Am, 13, pp. 215-233, (1987)
[4]  
Murphy G, Current views on proteolytic events in matrix degradation, Osteoarthritis Current Research and Prospects for Pharmacological Intervention, (1991)
[5]  
Okada Y, Nagase H, Harris ED, A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components: purification and characterization, J Biol Chem, 261, pp. 14245-14255, (1986)
[6]  
Okada Y, Konomi H, Yada T, Kimata K, Nagase H, Degradation of type IX collagen by matrix metalloproteinase‐3 (stromelysin) from human rheumatoid cells, FEBS Lett, 244, pp. 473-476, (1989)
[7]  
Wu JJ, Lark MW, Chun LE, Eyre DR, Sites of stromelysin cleavage in collagen types II, IX, X and XI of cartilage, J Biol Chem, 266, pp. 5625-5628, (1991)
[8]  
Saus J, Quinones S, Otani Y, Nagase H, Harris ED, Kurkinen M, The complete primary structure of matrix metalloproteinase‐3: identity with stromelysin, J Biol Chem, 263, pp. 6742-6745, (1988)
[9]  
Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJP, Stromelysin is an activator of procollagenase: a study with natural and recombinant enzymes, Biochem J, 248, pp. 265-268, (1987)
[10]  
Dean DD, Woessner JF, Extracts of human articular cartilage contain an inhibitor of tissue metalloproteinases, Biochem J, 218, pp. 277-280, (1984)